AAAAAA
Results: 26-42/42
Authors:
Schmoll, HJ
Citation: Hj. Schmoll, Active specific immunotherapy for human colon cancer, STRAH ONKOL, 176(1), 2000, pp. 47-48
Authors:
Brieger, P
Marneros, A
Wolf, HH
Schmoll, HJ
Citation: P. Brieger et al., Manic episode in an ifosfamide-treated patient, GEN HOSP PS, 22(1), 2000, pp. 52-53
Authors:
Schmiegel, W
Adler, G
Fruhmorgen, P
Folsch, U
Graeven, U
Layer, P
Petrasch, S
Porschen, R
Pox, C
Sauerbruch, T
Schmoll, HJ
Zeitz, M
Citation: W. Schmiegel et al., Colorectal cancer: Prevention and early detection in the general population - management in population at risk - endoscopic diagnosis, therapy and follow-up of polyps and cancer, Z GASTROENT, 38(1), 2000, pp. 49-75
Authors:
Dempke, W
von Poblozki, A
Kellner, O
Wolf, HH
Schmoll, HJ
Citation: W. Dempke et al., Hemorrhagic disorder as initial manifestation of metastatic gastric cancer, WIEN KLIN W, 112(24), 2000, pp. 1053-1058
Authors:
Kellner, O
Dempke, W
Schmoll, HJ
Citation: O. Kellner et al., Glucose infusions - Possible effective treatment option in Ifosfamide-induced encephalopathy, DEUT MED WO, 124(37), 1999, pp. 1086-1087
Authors:
Dempke, W
Voigt, W
Grothey, A
Schmoll, HJ
Citation: W. Dempke et al., Preferential repair of the N-ras gene in K 562 cells after exposure to cisplatin, ANTI-CANC D, 10(6), 1999, pp. 545-549
Authors:
Bokemeyer, C
Gerl, A
Schoffski, P
Harstrick, A
Niederle, N
Beyer, J
Casper, J
Schmoll, HJ
Kanz, L
Citation: C. Bokemeyer et al., Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer, J CL ONCOL, 17(2), 1999, pp. 512-516
Authors:
Dempke, W
Behrmann, C
Schober, C
Buchele, T
Grothey, A
Schmoll, HJ
Citation: W. Dempke et al., Diagnostic and therapeutic management of superior vena cava syndrome, MED KLIN, 94(12), 1999, pp. 681-684
Authors:
Dempke, W
Grothey, A
Schmoll, HJ
Citation: W. Dempke et al., Therapeutic management of pleural and pericardial effusions, ONKOLOGIE, 22(6), 1999, pp. 526-529
Authors:
Grothey, A
Voigt, W
Schober, C
Muller, T
Dempke, W
Schmoll, HJ
Citation: A. Grothey et al., The role of insulin-like growth factor I and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors, J CANC RES, 125(3-4), 1999, pp. 166-173
Authors:
Schmoll, HJ
Buchele, T
Grothey, A
Dempke, W
Citation: Hj. Schmoll et al., Where do we stand with 5-fluorouracil?, SEMIN ONCOL, 26(6), 1999, pp. 589-605
Authors:
Bokemeyer, C
Bamberg, M
Albers, J
Schmoll, HJ
Weissbach, L
Citation: C. Bokemeyer et al., UICC Symposium on Testicular Cancer: Guidelines for Standard Care and Future Prospects, INT J CANC, 83(6), 1999, pp. 808-808
Authors:
Bokemeyer, C
Kollmannsberger, C
Harstrick, A
Beyer, J
Gerl, A
Casper, J
Metzner, B
Hartmann, JT
Schmoll, HJ
Kanz, L
Citation: C. Bokemeyer et al., Treatment of patients with cisplatin-refractory testicular germ-cell cancer, INT J CANC, 83(6), 1999, pp. 848-851
Authors:
Fossa, SD
Bokemeyer, C
Gerl, A
Culine, S
Jones, WG
Mead, GM
Germa-Luch, JR
Pont, J
Schmoll, HJ
Tjulandin, S
Citation: Sd. Fossa et al., Treatment outcome of patients with brain metastases from malignant germ cell tumors, CANCER, 85(4), 1999, pp. 988-997
Authors:
Hartmann, JT
Albrecht, C
Schmoll, HJ
Kuczyk, MA
Kollmannsberger, C
Bokemeyer, C
Citation: Jt. Hartmann et al., Long-term effects on sexual function and fertility after treatment of testicular cancer, BR J CANC, 80(5-6), 1999, pp. 801-807
Authors:
Schmoll, HJ
Citation: Hj. Schmoll, Is there a standard adjuvant treatment for rectal cancer? Arbiter, EUR J CANC, 34(12), 1998, pp. 1833-1835
Authors:
Bokemeyer, C
Harstrick, A
Beyer, J
Metzner, B
Ruther, U
Hartmann, JT
Holstein, K
Derig, HG
De Wit, R
Casper, J
Schoffski, P
Kuhrer, I
Illiger, HJ
Kempf, B
Reichle, A
Foller, A
Hossfeld, DK
Fischer, JT
Berdel, WE
Gerhartz, HH
Kirchner, H
Pfluger, KH
Ostermann, H
Kanz, L
Schmoll, HJ
Citation: C. Bokemeyer et al., The use of intensive chemotherapy for non-seminomatous testicular germ cell tumors, EUROCANCER 98, 1998, pp. 321-323